<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Xiao S</submitter><funding>NCATS NIH HHS</funding><funding>NIDDK NIH HHS</funding><funding>NHLBI NIH HHS</funding><pubmed_abstract>Metformin is a widely prescribed anti-diabetic medicine that also reduces body weight. The mechanisms that mediate metformin's effects on energy balance remain incompletely defined. Here we show that metformin is a powerful pharmacological inducer of the anorexigenic metabolite Lac-Phe in mice as well as in two independent human cohorts. In cell culture, metformin drives Lac-Phe biosynthesis via inhibition of complex I, increased glycolytic flux, and intracellular lactate mass action. Other biguanides and structurally distinct inhibitors of oxidative phosphorylation also increase Lac-Phe levels &lt;i>in vitro&lt;/i>. Genetic ablation of CNDP2, the principal biosynthetic enzyme for Lac-Phe, in mice renders animals resistant to metformin's anorexigenic and anti-obesity effects. Mediation analyses </pubmed_abstract><journal>bioRxiv : the preprint server for biology</journal><pagination>2023.11.02.565321</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10635077</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Lac-Phe mediates the anti-obesity effect of metformin.</pubmed_title><pmcid>PMC10635077</pmcid><funding_grant_id>UL1 TR001420</funding_grant_id><funding_grant_id>K08 HL145095</funding_grant_id><funding_grant_id>UL1 TR001881</funding_grant_id><funding_grant_id>N01 HC095166</funding_grant_id><funding_grant_id>N01 HC095165</funding_grant_id><funding_grant_id>N01 HC095168</funding_grant_id><funding_grant_id>N01 HC095167</funding_grant_id><funding_grant_id>N01 HC095169</funding_grant_id><funding_grant_id>75N92020D00007</funding_grant_id><funding_grant_id>N01 HC095160</funding_grant_id><funding_grant_id>N01 HC095162</funding_grant_id><funding_grant_id>N01 HC095161</funding_grant_id><funding_grant_id>N01 HC095164</funding_grant_id><funding_grant_id>N01 HC095163</funding_grant_id><funding_grant_id>75N92020D00001</funding_grant_id><funding_grant_id>75N92020D00002</funding_grant_id><funding_grant_id>P30 DK040561</funding_grant_id><funding_grant_id>75N92020D00005</funding_grant_id><funding_grant_id>75N92020D00006</funding_grant_id><funding_grant_id>75N92020D00003</funding_grant_id><funding_grant_id>75N92020D00004</funding_grant_id><funding_grant_id>UL1 TR000040</funding_grant_id><funding_grant_id>HHSN268201500003C</funding_grant_id><funding_grant_id>UL1 TR001079</funding_grant_id><funding_grant_id>N01 HC095159</funding_grant_id><funding_grant_id>R01 HL151855</funding_grant_id><funding_grant_id>UM1 DK078616</funding_grant_id><funding_grant_id>P30 DK063491</funding_grant_id><funding_grant_id>R01 HL105756</funding_grant_id><funding_grant_id>HHSN268201500003I</funding_grant_id><pubmed_authors>Deng S</pubmed_authors><pubmed_authors>Gerszten RE</pubmed_authors><pubmed_authors>Rotter JI</pubmed_authors><pubmed_authors>Li VL</pubmed_authors><pubmed_authors>Guo X</pubmed_authors><pubmed_authors>Lyu X</pubmed_authors><pubmed_authors>Chen ZZ</pubmed_authors><pubmed_authors>Rich SS</pubmed_authors><pubmed_authors>Clish CB</pubmed_authors><pubmed_authors>Wei W</pubmed_authors><pubmed_authors>Shi X</pubmed_authors><pubmed_authors>Farrell L</pubmed_authors><pubmed_authors>Tiwari G</pubmed_authors><pubmed_authors>Long JZ</pubmed_authors><pubmed_authors>Ida Chen YD</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Tahir UA</pubmed_authors><pubmed_authors>Knowles JW</pubmed_authors><pubmed_authors>Taylor KD</pubmed_authors><pubmed_authors>Benson MD</pubmed_authors><pubmed_authors>Wood AC</pubmed_authors><pubmed_authors>Zheng S</pubmed_authors><pubmed_authors>Abbasi F</pubmed_authors><pubmed_authors>Xiao S</pubmed_authors><pubmed_authors>Goodarzi MO</pubmed_authors><pubmed_authors>Lange LA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Lac-Phe mediates the anti-obesity effect of metformin.</name><description>Metformin is a widely prescribed anti-diabetic medicine that also reduces body weight. The mechanisms that mediate metformin's effects on energy balance remain incompletely defined. Here we show that metformin is a powerful pharmacological inducer of the anorexigenic metabolite Lac-Phe in mice as well as in two independent human cohorts. In cell culture, metformin drives Lac-Phe biosynthesis via inhibition of complex I, increased glycolytic flux, and intracellular lactate mass action. Other biguanides and structurally distinct inhibitors of oxidative phosphorylation also increase Lac-Phe levels &lt;i>in vitro&lt;/i>. Genetic ablation of CNDP2, the principal biosynthetic enzyme for Lac-Phe, in mice renders animals resistant to metformin's anorexigenic and anti-obesity effects. Mediation analyses </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Nov</publication><modification>2026-06-08T03:27:25.587Z</modification><creation>2026-06-08T03:14:21.513Z</creation></dates><accession>S-EPMC10635077</accession><cross_references><pubmed>37961394</pubmed><doi>10.1101/2023.11.02.565321</doi></cross_references></HashMap>